SNCA and Parkinson disease: Moreover, EGCG has been found to protect against the accumulation of toxic protein aggregates, such as beta-amyloid plaques and alpha-synuclein fibrils, which are hallmark features of Alzheimer’s and Parkinson’s diseases, respectively.